Point of care tool: A two-part (I, II) tool to identify individuals likely to benefit from a genomic risk assessment (I) and those predicted to be at increased risk to carry a mutation in the BRCA1 or BRCA2 genes (II). (July 2023)

GECKO on the run: A 2-page, evidence-based summary for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (April 2016; Under review)

GECKO deep dive: A 16-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more. (Updated September 2023)